论文部分内容阅读
肺癌是最常见的恶性肿瘤之一,全球范围内肺癌死亡率均居恶性肿瘤之首。目前国际上倾向于将肺癌分为小细胞肺癌和NSCLC。NSCLC占肺癌的85%以上,其中85%以上又都属中晚期肺癌而失去根治性手术治疗的机会。化疗作为肺癌的主要治疗手段之一,可以改善肺癌患者的临床症状和延长生存期
Lung cancer is one of the most common malignancies. Lung cancer mortality ranks first among malignant tumors worldwide. At present, the international community tends to divide lung cancer into small cell lung cancer and NSCLC. NSCLC accounts for more than 85% of lung cancers, of which more than 85% are all advanced lung cancer and have lost the chance of radical surgical treatment. Chemotherapy as one of the main treatments for lung cancer can improve clinical symptoms and prolong survival of patients with lung cancer